1. Home
  2. HUMA vs OPFI Comparison

HUMA vs OPFI Comparison

Compare HUMA & OPFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HUMA
  • OPFI
  • Stock Information
  • Founded
  • HUMA 2004
  • OPFI 2009
  • Country
  • HUMA United States
  • OPFI United States
  • Employees
  • HUMA N/A
  • OPFI N/A
  • Industry
  • HUMA Biotechnology: Pharmaceutical Preparations
  • OPFI Finance: Consumer Services
  • Sector
  • HUMA Health Care
  • OPFI Finance
  • Exchange
  • HUMA Nasdaq
  • OPFI Nasdaq
  • Market Cap
  • HUMA 324.0M
  • OPFI 288.7M
  • IPO Year
  • HUMA N/A
  • OPFI N/A
  • Fundamental
  • Price
  • HUMA $1.67
  • OPFI $9.75
  • Analyst Decision
  • HUMA Strong Buy
  • OPFI Buy
  • Analyst Count
  • HUMA 7
  • OPFI 2
  • Target Price
  • HUMA $10.00
  • OPFI $11.75
  • AVG Volume (30 Days)
  • HUMA 7.5M
  • OPFI 875.7K
  • Earning Date
  • HUMA 11-07-2025
  • OPFI 10-29-2025
  • Dividend Yield
  • HUMA N/A
  • OPFI 2.56%
  • EPS Growth
  • HUMA N/A
  • OPFI N/A
  • EPS
  • HUMA N/A
  • OPFI 0.14
  • Revenue
  • HUMA $818,000.00
  • OPFI $335,437,000.00
  • Revenue This Year
  • HUMA N/A
  • OPFI $118.17
  • Revenue Next Year
  • HUMA $1,468.13
  • OPFI $11.29
  • P/E Ratio
  • HUMA N/A
  • OPFI $72.21
  • Revenue Growth
  • HUMA N/A
  • OPFI 28.69
  • 52 Week Low
  • HUMA $1.15
  • OPFI $4.83
  • 52 Week High
  • HUMA $6.77
  • OPFI $17.73
  • Technical
  • Relative Strength Index (RSI)
  • HUMA 47.73
  • OPFI 44.05
  • Support Level
  • HUMA $1.65
  • OPFI $9.00
  • Resistance Level
  • HUMA $1.78
  • OPFI $11.09
  • Average True Range (ATR)
  • HUMA 0.10
  • OPFI 0.55
  • MACD
  • HUMA -0.01
  • OPFI 0.03
  • Stochastic Oscillator
  • HUMA 23.73
  • OPFI 35.89

About HUMA Humacyte Inc.

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

About OPFI OppFi Inc.

OppFi Inc is a tech-enabled, mission-driven specialty finance platform that broadens the reach of community banks to extend credit access to everyday Americans. It recognizes revenue through finance charges on installment and SalaryTap contracts based on the interest method.

Share on Social Networks: